Cholesterol (LDL-C) and triglyceride (TG) levels are pivotal in assessing cardiovascular risk and cardiometabolic health. They can arise from a variety of sources, including genetic predispositions, lifestyle choices, and underlying health conditions, making personalized management strategies crucial.
The processing of cholesterol is strongly impacted by genetics, significantly shaping individual responses to different treatments. Innovations in medical diagnostics, such as the coronary artery calcium score, have enhanced our ability to tailor cholesterol management, moving beyond a one-size-fits-all approach. This evolution in understanding also means that individuals who experience side effects from statins now have access to a spectrum of effective alternatives.
Similarly, triglyceride levels are closely linked to dietary habits, metabolic health, and even the impact of certain medications. Elevated triglycerides often signal issues with metabolism and are frequently associated with conditions like obesity, insulin resistance and metabolic syndrome.
At Advocare Princeton Cardiometabolic Health, our approach is holistic and patient-centered. We delve into your lab results, place them within the context of your overall health, and employ tools, including coronary artery calcium scoring and other lab tests including lipoprotein(a) and apolipoprotein B, to refine your risk assessment. Our goal is to empower you with a deeper understanding of your health, enabling informed decisions and personalized strategies to optimize your cardiometabolic well-being.
